sensory ataxia
Recently Published Documents


TOTAL DOCUMENTS

88
(FIVE YEARS 18)

H-INDEX

15
(FIVE YEARS 1)

Author(s):  
Sien H. Van Daele ◽  
Matthieu Moisse ◽  
Valérie Race ◽  
Amélie Van Eesbeeck ◽  
Liesbeth Keldermans ◽  
...  

2021 ◽  
pp. postgradmedj-2021-140742
Author(s):  
Kiren George Koshy ◽  
Saraswati Nashi ◽  
Girish Baburao Kulkarni ◽  
B N Nandeesh
Keyword(s):  

2021 ◽  
pp. practneurol-2021-003044
Author(s):  
Alexander Grundmann ◽  
David Ledingham ◽  
Marc Hardwick ◽  
James Miller

2021 ◽  
Vol 15 ◽  
Author(s):  
Qing Zhang ◽  
Xihui Zhou ◽  
Yajun Li ◽  
Xiaodong Yang ◽  
Qammer H. Abbasi

Ataxia is a kind of external characteristics when the human body has poor coordination and balance disorder, it often indicates diseases in certain parts of the body. Many internal factors may causing ataxia; currently, observed external characteristics, combined with Doctor’s personal clinical experience play main roles in diagnosing ataxia. In this situation, different kinds of diseases may be confused, leading to the delay in treatment and recovery. Modern high precision medical instruments would provide better accuracy but the economic cost is a non-negligible factor. In this paper, novel non-contact sensing technique is used to detect and distinguish sensory ataxia and cerebellar ataxia. Firstly, Romberg’s test and gait analysis data are collected by the microwave sensing platform; then, after some preprocessing, some machine learning approaches have been applied to train the models. For Romberg’s test, time domain features are considered, the accuracy of all the three algorithms are higher than 96%; for gait detection, Principal Component Analysis (PCA) is used for dimensionality reduction, and the accuracies of Back Propagation (BP) neural Network, Support Vector Machine (SVM), and Random Forest (RF) are 97.8, 98.9, and 91.1%, respectively.


2021 ◽  
Vol 3 (1) ◽  
Author(s):  
Ji-Won Kim ◽  
Nuran Abdullayev ◽  
Janina Neuneier ◽  
Gereon R. Fink ◽  
Helmar C. Lehmann

AbstractSince the outbreak of coronavirus disease 2019 (COVID-19), a growing number of cases of acute transverse myelitis associated with COVID-19 have been reported. Here, we present the case of a patient who developed sensory ataxia after COVID-19 with MR lesions suggestive for longitudinal myelitis and in the splenium of the corpus callosum. The patient was successfully treated with immunoadsorption.


2020 ◽  
Vol 7 (1) ◽  
pp. e541
Author(s):  
Stefano Tozza ◽  
Andrea Cortese ◽  
Aniello Iovino ◽  
Marcello Esposito ◽  
Natalia Dominik ◽  
...  

Medicine ◽  
2020 ◽  
Vol 99 (29) ◽  
pp. e21124
Author(s):  
Kuan-Yu Lu ◽  
Ka-Fai Yuen ◽  
Jia-Yuan Luo ◽  
Chang-Zern Hong ◽  
Li-Wei Chou

Glia ◽  
2020 ◽  
Author(s):  
Masao Horie ◽  
Nozomu Yoshioka ◽  
Satoshi Kusumi ◽  
Hiromi Sano ◽  
Masayuki Kurose ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Jasmine Shimin Koh ◽  
James Wei Min Tung ◽  
Genevieve Lynn Yu Tan-Yu ◽  
Thirugnanam Umapathi

Chronic immune sensory polyradiculopathy (CISP) is an uncommon and treatable inflammatory disorder of the proximal sensory nerve roots. Patients typically present with severe sensory ataxia, normal motor examination, unsteady gait, and normal nerve conduction studies (NCS). We describe an elderly man who presented with a two-week history of progressive numbness of both legs and recurrent falls. He had hyporeflexia, normal strength, severe proprioceptive, and vibration sense loss in both lower limbs and was unable to stand or walk because of severe sensory ataxia. The NCS and MR scan of the spine were normal. Tibial somatosensory evoked potentials revealed proximal conduction defect and localized the pathology to the lumbar sensory nerve roots proximal to the dorsal root ganglion. Cerebrospinal fluid showed cytoalbuminergic dissociation suggestive of inflammation. CISP was diagnosed; he was given aggressive immunotherapy consisting sequentially of corticosteroids with mycophenolate mofetil and three cycles of intravenous immunoglobulin after which he regained independent mobility. Unlike previous reports where patients presented months-years after symptom onset and improved after single-line immunotherapy, our patient presented fairly acutely and made dramatic improvement only after aggressive combination therapy. We urge physicians to recognize this uncommon neurologic cause of sensory ataxia where early aggressive treatment is crucial for better functional outcomes.


Sign in / Sign up

Export Citation Format

Share Document